Baylor College of Medicine initiates research with Nautilus Biotechnology Voyager Platform

Baylor College of Medicine initiates research with Nautilus Biotechnology Voyager Platform
Nautilus Biotechnology launches early access

Nautilus Biotechnology has announced Baylor College of Medicine as the inaugural customer for its Iterative Mapping Early Access Program.

Under a research initiative led by professors Bing Zhang, Ph.D. and Yongchao Dou, Ph.D., Baylor researchers will use the Nautilus Voyager Platform to tackle complex scientific questions. The collaboration is positioned to advance early-stage applications of Nautilus Biotechnology’s proteomics technology.

The Baylor collaboration marks another significant milestone as Nautilus Biotechnology extends the reach of its proteomics technology. Recent developments build upon the company’s earlier focus, including the high-profile engagement with US HUPO President-Elect Olga Vitek on advancing statistical rigor in proteomics research, as detailed in Nautilus Biotechnology’s proteomics episode. This momentum also follows strategic leadership appointments designed to accelerate commercial growth, such as the selection of Amber Faust as Vice President of Sales to drive proteomics expansion.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.